Upgrading Category III Antiperspirants to Category I (43 FR 46728-46731)

Issue Date: October 1, 1978
Issued by: Center for Drug Evaluation and Research
Topic(s): Over-the-Counter Drugs
Status: Final

Upgrading Category III Antiperspirants to Category I (43 FR 46728-46731)

The guidelines recommended in this document for the studies required to bring a Category III antiperspirant drug product into Category I are in accord with the present state of the art and do not preclude the use of any advances or improved technology in the future.

Download the Guidance Document

webmaster1978-10-01T00:00:00+00:00

ABOUT US

Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.